The objective of this study was to elucidate the clinical significance of APE1 in ESCC, to develop a prognostic model utilizing molecular characteristics, and to establish a theoretical framework for the advancement of personalized treatment strategies. This evidence concerns the gene APEX1 and esophageal squamous cell carcinoma.